Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01871675 |
| Title | Phase Ib Study of IPI-145 in Combination With Bendamustine, Rituximab or Bendamustine/Rituximab in Hematologic Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| Florida Cancer Specialists | Sarasota | Florida | 34232 | United States | Details | |
| Oklahoma University | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | United States | Details |